IMCRImmunocore Holdings plc

Nasdaq immunocore.com


$ 34.77 $ -2.10 (-5.71 %)    

Tuesday, 02-Jul-2024 14:40:57 EDT
QQQ $ 486.12 $ 6.23 (1.3 %)
DIA $ 392.69 $ 1.85 (0.47 %)
SPY $ 547.66 $ 3.92 (0.72 %)
TLT $ 90.36 $ -0.31 (-0.34 %)
GLD $ 215.13 $ -0.14 (-0.07 %)
$ 36.43
$ 36.88
$ 0.00 x 0
$ 34.77 x 210
$ 34.62 - $ 36.88
$ 33.05 - $ 76.98
573,646
na
1.82B
$ 0.63
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-08-2024 03-31-2024 10-Q
2 02-28-2024 12-31-2023 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-buy-on-immunocore-hldgs-maintains-100-price-target

HC Wainwright & Co. analyst Patrick Trucchio reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $100 pri...

 needham-reiterates-buy-on-immunocore-hldgs-maintains-81-price-target

Needham analyst Gil Blum reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $81 price target.

 hc-wainwright--co-reiterates-buy-on-immunocore-hldgs-maintains-100-price-target

HC Wainwright & Co. analyst Patrick Trucchio reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $100 pri...

 needham-reiterates-buy-on-immunocore-hldgs-maintains-81-price-target

Needham analyst Gil Blum reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $81 price target.

 hc-wainwright--co-reiterates-buy-on-immunocore-hldgs-maintains-100-price-target

HC Wainwright & Co. analyst Patrick Trucchio reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $100 pri...

 needham-reiterates-buy-on-immunocore-hldgs-maintains-81-price-target

Needham analyst Gil Blum reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $81 price target.

 mizuho-maintains-buy-on-immunocore-hldgs-lowers-price-target-to-88

Mizuho analyst Graig Suvannavejh maintains Immunocore Hldgs (NASDAQ:IMCR) with a Buy and lowers the price target from $90 to...

 canaccord-genuity-maintains-hold-on-immunocore-hldgs-raises-price-target-to-67

Canaccord Genuity analyst Bill Maughan maintains Immunocore Hldgs (NASDAQ:IMCR) with a Hold and raises the price target from...

 hc-wainwright--co-maintains-buy-on-immunocore-hldgs-raises-price-target-to-100

HC Wainwright & Co. analyst Patrick Trucchio maintains Immunocore Hldgs (NASDAQ:IMCR) with a Buy and raises the price ta...

 needham-reiterates-buy-on-immunocore-hldgs-maintains-81-price-target

Needham analyst Gil Blum reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $81 price target.

 leerink-partners-initiates-coverage-on-immunocore-hldgs-with-outperform-rating-announces-price-target-of-74

Leerink Partners analyst Jonathan Chang initiates coverage on Immunocore Hldgs (NASDAQ:IMCR) with a Outperform rating and an...

 guggenheim-reiterates-buy-on-immunocore-hldgs-maintains-92-price-target

Guggenheim analyst Michael Schmidt reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $92 price target.